H.B. Fuller (NYSE:FUL) Price Target Raised to $72.00 at Citigroup

H.B. Fuller (NYSE:FULGet Rating) had its price objective increased by Citigroup from $65.00 to $72.00 in a research note published on Monday, The Fly reports.

Several other analysts also recently issued reports on FUL. Deutsche Bank Aktiengesellschaft lifted their price target on H.B. Fuller from $72.00 to $78.00 in a research note on Friday. StockNews.com began coverage on H.B. Fuller in a research note on Wednesday, October 12th. They issued a hold rating on the stock. Finally, Robert W. Baird dropped their price target on H.B. Fuller from $85.00 to $80.00 and set an outperform rating on the stock in a research note on Friday. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, H.B. Fuller has an average rating of Hold and an average price target of $70.50.

H.B. Fuller Stock Performance

Shares of H.B. Fuller stock opened at $68.54 on Monday. The company has a market capitalization of $3.65 billion, a PE ratio of 21.02 and a beta of 1.54. H.B. Fuller has a 12 month low of $57.36 and a 12 month high of $81.41. The company has a current ratio of 1.84, a quick ratio of 1.14 and a debt-to-equity ratio of 1.08. The stock’s fifty day simple moving average is $75.08 and its 200 day simple moving average is $68.70.

Insider Activity

In other news, CEO James Owens sold 79,061 shares of the firm’s stock in a transaction dated Monday, November 7th. The stock was sold at an average price of $71.07, for a total value of $5,618,865.27. Following the completion of the transaction, the chief executive officer now owns 163,703 shares in the company, valued at approximately $11,634,372.21. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, EVP Zhiwei Cai sold 2,746 shares of H.B. Fuller stock in a transaction dated Wednesday, November 9th. The stock was sold at an average price of $71.91, for a total transaction of $197,464.86. Following the completion of the transaction, the executive vice president now owns 28,733 shares in the company, valued at $2,066,190.03. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO James Owens sold 79,061 shares of H.B. Fuller stock in a transaction dated Monday, November 7th. The stock was sold at an average price of $71.07, for a total value of $5,618,865.27. Following the transaction, the chief executive officer now owns 163,703 shares of the company’s stock, valued at approximately $11,634,372.21. The disclosure for this sale can be found here. Insiders sold 200,357 shares of company stock worth $14,707,214 in the last quarter. Corporate insiders own 4.69% of the company’s stock.

Hedge Funds Weigh In On H.B. Fuller

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Bank of New York Mellon Corp grew its holdings in H.B. Fuller by 2.8% during the third quarter. Bank of New York Mellon Corp now owns 617,129 shares of the specialty chemicals company’s stock worth $37,090,000 after purchasing an additional 17,027 shares during the period. Public Employees Retirement Association of Colorado grew its holdings in H.B. Fuller by 3.3% during the third quarter. Public Employees Retirement Association of Colorado now owns 325,374 shares of the specialty chemicals company’s stock worth $19,555,000 after purchasing an additional 10,506 shares during the period. Luminus Management LLC grew its holdings in H.B. Fuller by 109.8% during the second quarter. Luminus Management LLC now owns 107,827 shares of the specialty chemicals company’s stock worth $6,492,000 after purchasing an additional 56,427 shares during the period. UBS Asset Management Americas Inc. grew its holdings in H.B. Fuller by 4.9% during the second quarter. UBS Asset Management Americas Inc. now owns 66,538 shares of the specialty chemicals company’s stock worth $4,006,000 after purchasing an additional 3,081 shares during the period. Finally, Dorsey & Whitney Trust CO LLC boosted its holdings in shares of H.B. Fuller by 1.8% during the second quarter. Dorsey & Whitney Trust CO LLC now owns 60,092 shares of the specialty chemicals company’s stock worth $3,618,000 after acquiring an additional 1,090 shares during the period. Institutional investors own 96.53% of the company’s stock.

H.B. Fuller Company Profile

(Get Rating)

H.B. Fuller Co engages in the manufacture and marketing of adhesives, sealants, and other specialty chemical products. It operates through the following segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives, and Construction Adhesives. The Hygiene, Health and Consumable Adhesives segment supplies adhesive products in the assembly, packaging, converting, nonwoven, hygiene, health and beauty, flexible packaging, graphic arts and envelope markets.

See Also

The Fly logo

Receive News & Ratings for H.B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H.B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.